Aarti Pharmalabs Limited (AARTIPHARM) — Announcement | 10 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Audio recording of earnings conference call uploaded
💡 Investor Takeaway
Shareholders can access the call recording to review Q1 FY27 results commentary.

Aarti Pharmalabs Limited announced that the audio recording of its earnings conference call for Q1 FY27, covering unaudited financial results for the quarter ended June 30, 2026, is now available on its website at https://www.aartipharmalabs.com/q1-fy-27 for investors and analysts to access.

📄 View Original Announcement (PDF)

About Aarti Pharmalabs Limited (AARTIPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹7,657.91 Cr P/E: 35.9 ROE: 10.7% ROCE: 14.1% Div Yield: 0.41%

View full AARTIPHARM stock details →

📡 Get AI alerts when AARTIPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AARTIPHARM — Free

📊 More AARTIPHARM filings

See all AARTIPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AARTIPHARM files new disclosures

Track AARTIPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AARTIPHARM — Free

Free account · 2 AI queries/day